Kathleen McGroddy-Goetz - May 18, 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ Rachel Malina, Attorney-in-Fact for Kathleen McGroddy-Goetz
Stock symbol
TNDM
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 08:05 PM
Previous filing
Mar 16, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +2.02K +248.28% $0.00 2.84K May 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +2.02K $0.00* 0 May 18, 2022 Common Stock 2.02K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.
F3 Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.